Back to Search
Start Over
Anti-adalimumab and anti-certolizumab antibodies titers after discontinuation of adalimumab: two case reports.
- Source :
- Clinical Chemistry & Laboratory Medicine; Apr2020, Vol. 58 Issue 4, pe105-e108, 4p, 2 Charts
- Publication Year :
- 2020
-
Abstract
- It has been shown that in patients with rheumatoid arthritis, switched to a second anti-TNF drug for the development of ADAs against the starting agent, the clinical outcome may significantly ameliorate, even better than in patients not developing ADAs [7]. The immunogenicity to the first anti-TNF therapy determines the outcome of switching to a second anti-TNF therapy in spondyloarthritis patients. [Extracted from the article]
- Subjects :
- TUMOR necrosis factors
SARCOIDOSIS
ANTIBODY titer
LEUKOCYTE count
Subjects
Details
- Language :
- English
- ISSN :
- 14346621
- Volume :
- 58
- Issue :
- 4
- Database :
- Complementary Index
- Journal :
- Clinical Chemistry & Laboratory Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 142227390
- Full Text :
- https://doi.org/10.1515/cclm-2019-0950